Home › Kanser sa Suso › North Carolina › Durham
Pag-aaral pangklinika para sa Kanser sa Suso sa Durham, NC
64 pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Durham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
A Study of PHST001 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Nagre-recruitPhase 3
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
- University of North Carolina, Chapel Hill · 10 mi ang layo
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Nagre-recruitPhase 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
Nagre-recruitObservasyonal na pag-aaral
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Nagre-recruitPhase 1
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- University of North Carolina, Chapel Hill · 10 mi ang layo
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Nagre-recruitPhase 2
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Nagre-recruitPhase 3
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Nagre-recruitPhase 1
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Nagre-recruitPhase 3
- University of North Carolina Medical Center, Chapel Hill · 10 mi ang layo
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Nagre-recruitPhase 2
- University of North Carolina Medical Center, Chapel Hill · 10 mi ang layo
Identifying Patterns in the Breath of Individuals With Breast Cancer
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Nagre-recruitPhase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Nagre-recruitPhase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi ang layo
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Nagre-recruitPhase 3
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
Nagre-recruitObservasyonal na pag-aaral
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Nagre-recruitPhase 1/2
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Nagre-recruitPhase 1
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Nagre-recruitPhase 1/2
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Nagre-recruitPhase 3
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
Nagre-recruitPhase 2
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
Nagre-recruitPhase 2
- University of North Carolina, Chapel Hill · 10 mi ang layo
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Nagre-recruitPhase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mi ang layo
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Nagre-recruitPhase 2
- University of North Carolina, Chapel Hill · 10 mi ang layo
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Nagre-recruit
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
Nagre-recruitObservasyonal na pag-aaral
- University of North Carolina, Chapel Hill · 10 mi ang layo
Weight Management After Cancer for Survivors in Rural Communities
Nagre-recruit
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
Nagre-recruit
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Nagre-recruitPhase 2/3
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Nagre-recruit
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Nagre-recruitPhase 2
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
Nagre-recruit
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Nagre-recruitPhase 1
- University of North Carolina, Chapel Hill · 10 mi ang layo
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Nagre-recruit
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mi ang layo
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Nagre-recruit
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
Nagre-recruitObservasyonal na pag-aaral
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Nagre-recruitPhase 3
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Nagre-recruitPhase 1
- University of North Carolina, Chapel Hill · 10 mi ang layo
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
- The University of North Carolina, Chapel Hill · 10 mi ang layo
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
Nagre-recruitObservasyonal na pag-aaral
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
Nagre-recruitPhase 2
- University of North Carolina, Chapel Hill · 10 mi ang layo
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Nagre-recruit
- University of North Carolina, Chapel Hill · 10 mi ang layo
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Nagre-recruitPhase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi ang layo
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Nagre-recruitPhase 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
Nagre-recruitPhase 2
- University of North Carolina, Chapel Hill · 10 mi ang layo
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
Nagre-recruitPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Nagre-recruit
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Nagre-recruitPhase 1/2
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Nagre-recruitObservasyonal na pag-aaral
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Nagre-recruitPhase 2
- University of North Carolina, Chapel Hill · 10 mi ang layo
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Nagre-recruitPhase 1
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
Nagre-recruit
- UNC Cancer Hospital, Chapel Hill · 10 mi ang layo
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Nagre-recruit
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Nagre-recruit
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Nagre-recruit
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
BREAST Choice Decision Tool R21 - AIM2
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- The University of North Carolina, Chapel Hill · 10 mi ang layo
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Nagre-recruit
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi ang layo
UNC Pleural Fluid Registry
Nagre-recruitObservasyonal na pag-aaral
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
Pag-aaral para sa Kanser sa Suso sa ibang lungsod
- New York City, NY136 pag-aaral
- Houston, TX126 pag-aaral
- Boston, MA112 pag-aaral
- Nashville, TN81 pag-aaral
- Los Angeles, CA73 pag-aaral
- Edison, NJ68 pag-aaral
- St. Louis, MO64 pag-aaral
- Queens, NY64 pag-aaral
- Chicago, IL59 pag-aaral
- Philadelphia, PA56 pag-aaral
- Dallas, TX55 pag-aaral
- San Antonio, TX47 pag-aaral
Iba pang pag-aaral sa Durham
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer39 pag-aaral
- Multiple Myeloma37 pag-aaral
- Acute Myeloid Leukemia33 pag-aaral
- Metastatic Cancer33 pag-aaral
- Kanser sa Prostate32 pag-aaral
- Kanser sa Baga32 pag-aaral
- Colorectal Cancer28 pag-aaral
- Kanser sa Ovary27 pag-aaral
- Chronic Lymphocytic Leukemia27 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
- Kanser sa Pancreas24 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.